Literature DB >> 18486926

NK cells in autoimmunity: a two-edg'd weapon of the immune system.

Roberto Perricone1, Carlo Perricone, Caterina De Carolis, Yehuda Shoenfeld.   

Abstract

Natural killer (NK) cells are part of the innate-immune system and respond rapidly to a variety of insults via cytokine secretion and cytolytic activity. Their main function is first line of innate immunity across viral, bacterial and parasitic infections. NK-cells are not solely killers but can also act as regulators of adaptive immunity. It is evident from literature that NK-cells are deeply involved in autoimmunity, but the question is how and why they act as a two edged weapon. Number of circulating NK-cells can be frequently altered depending on the disease taken into consideration. Cytokine milieu, the microenvironment in which they mature and other stimuli acting on different cell surface receptors may differently trigger NK-cells response and influence their role in autoimmune diseases. Functional differences between NK-cells at different anatomical sites, the adaptability of NK-cells effector responses and genetic factors may also explain differences in such responses. Thus, NK-cell alterations may be associated with increased autoimmunity and the modulation in the number of circulating NK-cells seems to be a primary event rather than an active inflammation/drug administration consequence during inflammatory/autoimmune processes, playing a fundamental role in the pathogenesis of a number of autoimmune diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18486926     DOI: 10.1016/j.autrev.2008.03.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  26 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

2.  Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRalpha/beta+CD3+CD4-CD8- double-negative T cells.

Authors:  S Yeh; Z Li; H N Sen; W-K Lim; F Gill; K Perkins; V K Rao; R B Nussenblatt
Journal:  Br J Ophthalmol       Date:  2010-06       Impact factor: 4.638

3.  Pregnancy and catastrophic antiphospholipid syndrome.

Authors:  Jose A Gómez-Puerta; Jose Sanin-Blair; Claudio Galarza-Maldonado
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 4.  NK cell trafficking in health and autoimmunity:a comprehensive review.

Authors:  Hui Peng; Zhigang Tian
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

5.  Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure.

Authors:  P Triggianese; C Perricone; P Conigliaro; M S Chimenti; R Perricone; C De Carolis
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-10       Impact factor: 3.219

6.  Reproductive immunology: current status and future directions (part I).

Authors:  Elena Peeva
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

7.  Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.

Authors:  SuFey Ong; Davinna L Ligons; Jobert G Barin; Lei Wu; Monica V Talor; Nicola Diny; Jillian A Fontes; Elizabeth Gebremariam; David A Kass; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2015-01-23       Impact factor: 4.307

Review 8.  NK cells, autoantibodies, and immunologic infertility: a complex interplay.

Authors:  Caterina De Carolis; Carlo Perricone; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

9.  Natural killer (NK) cell deficit in coronary artery disease: no aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation.

Authors:  K Backteman; J Ernerudh; L Jonasson
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

Review 10.  New immunological approaches in treating and diagnosing CNS diseases.

Authors:  Kathy Guo; Damir Janigro
Journal:  Pharm Pat Anal       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.